Lifecore Biomedical Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -251.1% | – | – | +64.5% | -16.7% | -119.0% | – | -46.1% | -20.7% | +93.4% | +53.3% | -4.3% | -0.9% | +24.3% | -16.7% | +34.6% | -32.6% | -19.0% | -206.4% | – | -248.1% | – | – | -180.2% | – | |
| – | +120.0% | +90.9% | +4.8% | +175.7% | -10.5% | -35.5% | +5.9% | -6.4% | -7.6% | +1.8% | -1.7% | -2.0% | +7.2% | +57.9% | +5.8% | +29.8% | -2.5% | -0.3% | +32.5% | +13.6% | +16.2% | +22.7% | +23.7% | +5.5% | -10.0% | +1.0% | -56.0% | +0.9% | -15.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +8.9% | +92.0% | -4.0% | -9.5% | -20.0% | +16.3% | +119.7% | +14.4% | +11.1% | -19.1% | -99.9% | +141,373.7% | -22.4% | +0.0% | +137.8% | +63.8% | -39.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +1,400.3% | -36.3% | +226.3% | -47.9% | – | – | – | |
| – | – | – | – | – | – | – | – | +402.9% | -102.4% | – | – | -433.7% | – | – | – | -148.4% | – | – | -177.6% | – | -1,828.6% | – | – | – | -167.6% | – | – | – | – | |
| – | +225.0% | +246.2% | -8.9% | +30.2% | +30.4% | -63.4% | +33.3% | +7.8% | +29.7% | +42.9% | -37.5% | +7.9% | +880.6% | -85.1% | -19.6% | +65.3% | +67.7% | +17.6% | +133.4% | -44.7% | +48.7% | +33.2% | -40.3% | -5.5% | +11.5% | +6.4% | -38.6% | -27.1% | -52.8% | |
| – | – | -28.1% | -175.6% | +404.0% | -74.4% | – | -118.2% | +279.0% | +5.6% | – | -148.1% | -39.0% | +246.9% | -31.3% | +50.0% | -76.4% | +28.0% | +158.2% | +20.8% | -39.9% | +42.3% | +172.0% | -75.3% | -48.5% | – | -2.2% | -123.0% | -65.1% | -74.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -69.7% | – | – | – | +1,023.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +164.1% | – | – | – | +322.8% | -99.0% | +2,493.9% | -73.0% | – | – | +240.6% | -52.6% | -69.7% | +91.0% | – | – | -80.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -47.7% | -82.1% | -841.8% | – | -88.8% | -825.1% | – | |
| – | -126.4% | – | -78.8% | +2,328.7% | -31.6% | -171.1% | -54.0% | -62.2% | – | -9.5% | -852.0% | – | +901.1% | -124.2% | – | -153.6% | -62.7% | – | +90.6% | -156.5% | – | +494.5% | -49.4% | -108.5% | +1,567.8% | +0.0% | – | -14.4% | -117.2% | |
| – | -184.9% | – | -250.0% | – | -99.1% | -1,533.9% | – | +132.4% | +19.3% | +449.6% | -143.2% | – | – | – | – | -160.2% | – | -122.1% | – | – | – | – | – | – | -53.1% | +0.0% | -3,154.3% | – | – | |
| – | – | – | – | – | – | – | – | +106.8% | -34.8% | -244.5% | – | -63.4% | -869.5% | – | +115.9% | -26.5% | -50.1% | +40.3% | -320.8% | – | -305.1% | – | – | – | – | – | – | – | – |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.